Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 28, 2005
[A phase I study of TS-1 and weekly cisplatin in patients with advanced gastric cancer]Ken Kondo, Mizunobu Kinoshita, Masato Kataoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2004
[A case of recurrent advanced gastric cancer with lung metastasis effectively treated by combined chemotherapy of TS-1 and weekly CDDP]Satofumi Shimoyama, Ken Kondo, Masato Kataoka, et al.
Japanese Journal of Clinical Oncology|September 4, 2013
A phase II clinical study of mFOLFOX6 plus bevacizumab as first-line therapy for Japanese advanced/recurrent colorectal cancer patientsTomohiro Nishina, Yoshinao Takano, Tadamichi Denda, et al.
ISME Communications|December 10, 2025
Proliferation of a bloom-forming phytoplankton via uptake of polyphosphate-accumulating bacteria under phosphate-limiting conditionsSeiya Fukuyama, Fumiko Usami, Ryuichi Hirota, et al.
Japanese Journal of Clinical Oncology|June 18, 2005
Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancerKen Kondo, Michiya Kobayashi, Hiroshi Kojima, et al.
Surgical Case Reports|April 25, 2016
A resected case of symptomatic acinar cell cystadenoma of the pancreas displacing the main pancreatic ductHaruyoshi Tanaka, Tsuyoshi Hatsuno, Mitsuru Kinoshita, et al.
International Journal of Clinical Oncology|March 3, 2012
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF studyTakao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, et al.
Hepato-Gastroenterology|December 13, 2005
Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancerNaoki Nagata, Michiya Kobayashi, Hiroshi Kojima, et al.
Pageof 5